Edition:
United Kingdom

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

246.19USD
15 Oct 2018
Change (% chg)

$-2.06 (-0.83%)
Prev Close
$248.25
Open
$248.27
Day's High
$248.27
Day's Low
$246.19
Volume
2,516
Avg. Vol
83,114
52-wk High
$288.75
52-wk Low
$227.57

Latest Key Developments (Source: Significant Developments)

Teleflex Acquires Essential Medical
Thursday, 4 Oct 2018 

Oct 4 (Reuters) - Teleflex Inc ::TELEFLEX ACQUIRES ESSENTIAL MEDICAL.TELEFLEX INC - EXPECT ACQUISITION WILL BE MODESTLY ACCRETIVE TO CONSTANT CURRENCY REVENUE GROWTH AND GROSS MARGINS OVER A MULTI-YEAR PERIOD.TELEFLEX INC - MANTA DEVICE IS NOT APPROVED FOR SALE OR DISTRIBUTION IN UNITED STATES.TELEFLEX INC - ANTICIPATED FDA PREMARKET APPROVAL OF MANTA DEVICE IN 2019.  Full Article

Teleflex Reaffirms Previously Provided Financial Guidance For 2018
Friday, 11 May 2018 

May 11 (Reuters) - Teleflex Inc ::TELEFLEX SAYS REAFFIRMS PREVIOUSLY PROVIDED FINANCIAL GUIDANCE FOR 2018.TELEFLEX INC - SEES AVERAGE ORGANIC CONSTANT CURRENCY REVENUE GROWTH OF BETWEEN 6% AND 7% FROM 2019 THROUGH 2021 .TELEFLEX INC - SEES AVERAGE FREE CASH FLOW GENERATION OF BETWEEN $500 MLN AND $550 MLN FROM 2019 THROUGH 2021 .TELEFLEX INC <<>> FY2018 SHR VIEW $9.83, REV VIEW $2.48 BLN -- THOMSON REUTERS I/B/E/S.  Full Article

Teleflex Signs New Agreement With Healthtrust For Respiratory Heaters & Accessories
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Teleflex Inc ::TELEFLEX SIGNS NEW AGREEMENT WITH HEALTHTRUST FOR RESPIRATORY HEATERS & ACCESSORIES.TELEFLEX - AGREEMENT COVERS CO'S FULL LINE OF ACTIVE HUMIDIFICATION, NON INVASIVE VENTILATION, HIGH FLOW NASAL CANNULA THERAPY PRODUCTS.  Full Article

Teleflex announces pricing of $500 mln senior notes offering
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Teleflex Inc :Teleflex Incorporated announces pricing of $500 million senior notes offering.Teleflex Inc - ‍Priced offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 at an issue price of 100.000%​.  Full Article

Teleflex announces public offering of $500 mln of senior notes
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Teleflex Inc :Teleflex Incorporated announces public offering of $500 million of senior notes.Teleflex Inc - ‍intends to use net proceeds from offering to repay approximately $491.2 million of borrowings under its revolving credit facility​.Teleflex Inc - ‍registered public offering of $500.0 million aggregate principal amount of senior notes due 2027​.  Full Article

Teleflex reports Q3 adjusted profit of $2.12/shr
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Teleflex Inc :Teleflex reports third quarter 2017 results.Q3 adjusted earnings per share $2.12 from continuing operations.Q3 GAAP earnings per share $1.70 from continuing operations.Q3 revenue $534.7 million versus I/B/E/S view $523.1 million.Q3 earnings per share view $2.00 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $8.30 to $8.40 from continuing operations.Sees FY 2017 GAAP earnings per share $5.61 to $5.66 from continuing operations.‍lowered 2017 guidance for GAAP diluted EPS from a range of $5.91 to $5.98 to a range of $5.61 to $5.66​.Raised 2017 guidance for adjusted diluted EPS from a range of $8.20 to $8.35 to a range of $8.30 to $8.40.Teleflex Inc- co raised its full year 2017 GAAP revenue growth guidance range from 11.5 percent to 13.0 percent to a range of 15.0 percent to 15.5 percent over the prior year.FY 2017 earnings per share view $8.29, revenue view $2.11 billion -- Thomson Reuters I/B/E/S.Teleflex Inc - ‍raised 2017 guidance range for constant currency revenue growth to a range of 14.25 percent to 14.75 percent​.  Full Article

Teleflex's (TFX) Vascular Solutions issues recall of venture catheters
Thursday, 22 Jun 2017 

June 22 (Reuters) - Teleflex Inc ::Teleflex Inc says worldwide recall of venture catheters was voluntarily initiated by its unit Vascular Solutions on April 25, 2017.Says the worldwide recall affects 4,679 venture catheters units distributed in United States.Says no serious injuries or death have been reported in association with this issue to date.Says U.S. FDA classified the issue as a class I recall.Says Vascular Solutions has notified the FDA of the action.  Full Article